Table 7KQ1 - Baseline medical therapies

Study, yearGroupBBCCBASAClopidogrel or TiclopidineAntiplateletDiureticNitrateStatinLipid LoweringDigitalis
HOPE, 200038Ramipril 10mg/d
Placebo
39
40
46
48
75
77
15
15
28
29
PART-2, 200041Ramipril 5–10mg/d
Placebo
42
43
25
25
83
79
29
28
SCAT, 200042Enalapril 20mg/d
Placebo
49
46
16
13
91
89
62
66
49
51
EUROPA, 200343Perindopril 8mg/d
Placebo
62
61
32
31
92
93
9
9
43
43
58
57
Kondo et al, 200344Candesartan 4mg/d
Control
14
14
68
67
37
32
CAMELOT, 200445Enalapril 20mg/d
Amlodipine 10mg/d
Placebo
75
74
79
6
5
12
95
94
95
27
32
33
82
83
84
JMIC-B, 200446ACEI[proportional, variant]
Nifedipine 10–20mg/d
19
21
49
53
57
53
5
5
65
67
26
29
PEACE, 200447Trandolapril 4mg/d
Placebo
60
60
36
35
90
91
13
13
70
70
4
4
FOSIDIAL, 2006*48Fosinopril 20mg/d
Placebo
26
24
Takahashi et al, 200649Candesartan 4–8mg/d
Control
23

8
77

59
16

8
33

16
33

14
SMILE-ISCHEMIA, 200750Zofenopril 60mg/d
Placebo
10
12
3
6
3
10
1
7
10
23
28
32
TRANSCEND, 200851Telmisartan 80mg/d
Placebo
59
57
40
40
75
74
11
11
80
79
33
33
56
55

SCAT was a 2X2 factorial design with simvastain 40mg

[proportional, variant]

= Patients in the ACEI group were given enalapril 5–10mg/d, imidapril 5–10mg/d, or lisinopril 10–20mg/d

Abbreviations: ACEI=angiotensin converting enzyme inhibitor; ASA=aspirin; BB=beta-blocker; CCB=calcium channel blocker

= Patients in the ACEI group were given enalapril 5–10mg/d, imidapril 5–10mg/d, or lisinopril 10–20mg/d

From: Results

Cover of Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease [Internet].
Comparative Effectiveness Reviews, No. 18.
Coleman CI, Baker WL, Kluger J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.